Belite Bio’s $36 Million IPO

Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal. Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

AKMMeadville Electronics Co., Ltd’s $550 Million Acquisition of China Manufacturing Plants from TTM Technologies

O’Melveny advised TTM Technologies Inc. in the acquisition, while Tian Yuan assisted AKMMeadville Electronics. TM Technologies, Inc. (NASDAQ: TTMI) announced the execution of a definitive agreement under...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here